Ha finalizado sesión correctamente

¡Hola !
Cerrar sesión

Reducción de la subdosificación

Subdosificación

 una causa de errores de medicación

Información exclusiva para profesional sanitario

La información contenida en este sitio web está destinada exclusivamente a profesionales sanitarios. Absténgase de acceder si no es un profesional sanitario. Si es usted paciente, es importante que consulte a su médico.



Al aceptar, confirma que usted es profesional sanitario.


Aceptar Sí, soy profesional sanitario. Cancelar No, no soy profesional sanitario.
Gráfico de subdosis

En infusiones de pequeño volumen, hasta un 32,2 % del agente activo permanece en la línea IV3

Intrafix® SafeSet

Gravity sets (G) are IV administration sets for gravity infusion.Pressure set (P) are IV administration sets for gravity and pressure infusions with compatible (non-dedicated) infusion pumps (pressure resistant up to 2 bar acc. to ISO 8536-8)

Intrafix® SafeSet Type Flush

Innovative IV administration set with inline drip chamber and needle-free access port. In combination with Intrafix® Primeline Flush Secondary Line it offers the possibility to rinse the complete system after each drug with reduction of residual volume left in the line.IV administration gravity set (G) is an IV administration set for gravity infusions.IV administration pressure set (P) (pressure resistant acc. to ISO 8536-8) is an IV administration set.for gravity and pressure infusions with compatible infusion pumps (non-dedicated pump).

Infusomat®plus Line Type Flush (for short-term infusions)

Infusomat®plus Line Type Flushing Set are dedicated IV administration sets for the application of short term infusions (e.g. antibiotics) in combination with a connected secondary administration Set (Intrafix® Primeline). The lines are especially designed to improve short-term drug applications in combination with B. Braun Infusomat® compactplus. The line consists of PUR (not manufactured with PVC or with DEHP) and a silicon pump segment. The drip chamber is equipped with an AirStop filter (<15 μm pore size)  which avoids air entering the infusion system. At the end of the line each set has got a protective PrimeStop cap with a hydrophobic membrane which stops fluid leaking and protects against contamination. The color codes and shapes of the pump element guide the users while they are loading the pump quickly and safely.

Cyto-Set® Mix, Cyto-Set® Line

Single-use, sterile infusion system for the preparation and administration of different cytotoxic drugs via one single closed line-system by gravity or pressure with bottles and bags according to the SPC (Summary of product characteristics) of the drugs/solutions. Cyto-Set® is used for the application of cytotoxic agents in a closed system.The Cyto-Set® system reduces the probability of contamination of person and environment when preparing and applying cytotoxic drugs ensured by its technical components forming a closed system and the resulting workflow.Cyto-Set® MixConnection system for Cyto-Set® gravity infusion- and Infusomat® Space sets.The Cyto-Set® Mix allows to connect a normal infusion container with a solution dedicated for cytotoxic drugs (NaCl 0,9% or Glucose 5%) to vent the line. The drug is put in the container via a needle-free injection valve. So the line of the Cyto-Set® Mix leading to Cyto-Set® Infusion, Cyto-Set® Infusomat® Space or Cyto-Set® Infusomat® plus is free of cytotoxic drugs.Cyto-Set® LineConnection system for Cyto-Set® gravity infusion- and Infusomat® Space sets.Cyto-Set® Line connects primed solutions. This component consists of only one spike and a polyurethane transition tube, clamp and a fill-stop-cap (Prime Stop).Cyto-Set® can be used for all patients to whom cytotoxic drugs are prescribed in hospitals. Depending on the particular therapeutical concept and sensibility of the tumor to one or more cytotoxic agents the administration of these drugs represents an important role besides surgery and radiation therapy.

Dosifix®

Contains a metered small-volume chamber designed to limit the amount of solution available to the patient, usually for safety, but also as an intermittent infusion of medication that can be admixed immediately before infusion. Primarily required for pediatric and neonatal patients.Suitable for gravity infusions.

Omniflush®

Omniflush® is a normal saline I.V. flush syringe for flushing of compatible intravenous tubing and/or indwelling access devices.The ready-to-use flush system contains sterile solution and fluid path (QC002, SAL 10-6) and is packed inside a single unit tubular bag.

Omniflush® with SwabCap®

Omniflush® with SwabCap® is a normal saline I.V. flush syringe with an integrated SwabCap®. A SwabCap® is a luer access valve cap that contains 70% Isopropyl alcohol as a disinfectant. They are integrated together for the convenience of the user.

¿Quieres convencerte de las ventajas de Intrafix® Safeset ?


Solicita una muestra

(último acceso: junio de 2021)

 

[1] Toh MR et al., Prev Med Reports 2014;1:43-473. Plagge, H. et al., EJHPScience, 2010; 16:31-37

[2] Hughes RG et al., Manual basado en pruebas para enfermeros 2008; Departamento de Salud y Servicios Humanos de EE. UU.

[3] Plagge, H. et al., EJHPSCience, 2010; 16:31-37

[4] https://www.england.nhs.uk/signuptosafety/wp-content/uploads/sites/16/2015/11/su2s-infusing-iv-antibiotics-webinar.pdf

[5]. Cousins, D. et al., Clinical Pharmacist 2018;10(12):356-357

[6] Observador de seguridad del paciente, 2007

[7] Cooper DM et al., Bri J Nurs 2018; 27:2-6

[8] Gregerson BG et al. Proc Bayl Univ Med Cent 2018;31(2):168-170

[9] Chan YK y otros, CMBES Proc., vol. 36, n.o 1, mayo de 2013

[10] Carta de Cousins D en Clinical Pharmacist & Cooper et al.

[11] https://www.ismp.org/resources/hidden-medication-loss-when-using-primary-administration-set-small-volume-intermittent

[12] MacLachlan, L. et al., Antimicrobial Stewardship: garantía de administración de dosis completas prescritas de antibióticos IV en OPAT, Hull University Teaching Hospitals, NHS Trust

[13] Fish and Ohlinger, 2006

[14] CDC 2015, https://www.CDC.gov/drugresistance/biggest-threats.html

[15] Gurney, H. et al., Bri J Cancer 2002;86:1297-1302

[16] Bowman, S. et al., Anaesthesia 2013;68:57-561

[17] Cooper DM et al., BJON 2018;27:14(suppl_000

[18] https://www.ismp.org/resources/additional-strategies-improve-complete-delivery-small-volume-intermittent-infusions

[19] Peyko, V., Un problema no reconocido en la optimización de la terapia antimicrobiana: Volumen residual significativo restante en tubos intravenosos con piperacilina-tazobactam de infusión prolongada, volumen de Journal of Pharmacy Practice 2021. 0,0 1-4